Á¦ÀÏÄðÆÄÇÁ jeil COOL PAP
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¾Ë¸²:
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù.
Àü¹®/ÀϹÝ
ÀϹÝ
¹é»ö-´ãȸ¹é»öÀÇ ¾à¾×À» Æú¸®¿¡½ºÅÚ Çʸ§¿¡ µµÆ÷Çϰí(¹Ù¸£°í) ºÎÁ÷Æ÷¸¦ µ¤Àº °ÍÀ¸·Î ƯÀÌÇÑ ³¿»õ°¡Àִ īŸÇö󽺸¶Á¦
Á¦Á¶È¸»ç
Á¦ÀÏÇコ»çÀ̾ð½º(ÁÖ)
ÆÇ¸Åȸ»ç
Á¦ÀÏÇコ»çÀ̾ð½º(ÁÖ)
Çã°¡Á¤º¸
Á¤»ó
(1984.03.16)
BIT ¾àÈ¿ºÐ·ù
¿Ü¿ë ¼Ò¿°ÁøÅëÁ¦ (NSAIDs : Skin & Mucous Membrane)
º¹ÁöºÎºÐ·ù
264[ÁøÅ롤Áø¾ç¡¤¼ö·Å¡¤¼Ò¿°Á¦ ]
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå
054300130[645401460] [ºñ±Þ¿©]
ATCÄÚµå
Preparations with salicylic acid derivatives / M02AC
NDCÄÚµå
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
¼ººÐ / ÇÔ·®
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
÷°¡Á¦
±Û¸®¼¼¸° ,
µðºÎÆ¿È÷µå·Ï½ÃÅç·ç¿£ ,
·¯¹ö¶óÅØ½º ,
¹Ì³×¶öÀ¯ ,
¹ÐÂøÆ÷ ,
ºÎÁ÷Æ÷ ,
»êȾƿ¬ ,
»êÈÆ¼Åº ,
½ÃÆ®¸£»ê¼öȹ° ,
Á¤Á¦¼ö ,
Á©¶óƾ ,
Ä«¸£º¹½Ã¸ÞÆ¿¼¿·ê·Î¿À½º ³ªÆ®·ý ,
Ä«¸£º¹½Ã¸ÞÆ¿¼¿·ê·Î¿À½º³ªÆ®·ý ,
Ä«¿Ã¸° ,
Æú¸®ºÎÅÙ ,
Æú¸®¼Ò¸£º£ÀÌÆ®60 ,
Æú¸®¾ÆÅ©¸±»ê³ªÆ®·ý ,
Æú¸®¿¡½ºÅÚÇʸ§ ,
ÇǺêÀÌ¿¥¡¤¿¥¿¡À̰øÁßÇÕü
Á¦Ç°º° ¿¬·É±Ý±â °í½Ã
¼ººÐ¸í
¼ººÐÄÚµå
ƯÁ¤¿¬·É
°í½Ã¹øÈ£
°í½ÃÀÏÀÚ
ºñ°í
menthae oil
341700CPO
30 °³¿ù ÀÌÇÏ
20250046
2025-07-14
¼Ò¾Æ¿¡¼ °æ·ÃÀ» À¯¹ßÇÒ ¼ö ÀÖÀ½
À¯·áȸ¿ø °áÀç½Ã ¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸ ¸¦
ÀÌ¿ë ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯·áÁ¤º¸¸ñ·Ï Àº Àü¹®È¸¿ø À¸·Î
·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
Çã°¡Á¤º¸
Ç׸ñ
³»¿ë
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå »óÇѱݾ×
054300130[645401460]
[º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
[ºñ±Þ¿©]
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
ºü¸¥Á¶È¸
Á¦Ç°¼º»ó
¹é»ö-´ãȸ¹é»öÀÇ ¾à¾×À» Æú¸®¿¡½ºÅÚ Çʸ§¿¡ µµÆ÷Çϰí(¹Ù¸£°í) ºÎÁ÷Æ÷¸¦ µ¤Àº °ÍÀ¸·Î ƯÀÌÇÑ ³¿»õ°¡Àִ īŸÇö󽺸¶Á¦ [Á¦ÇüÁ¤º¸ È®ÀÎ]
Æ÷À塤À¯Åë´ÜÀ§
6¸Å
Æ÷À塤ÄÚµå´ÜÀ§
¾àǰ±Ô°Ý
´ÜÀ§
Æ÷ÀåÇüÅÂ
´ëÇ¥ÄÚµå
Ç¥ÁØÄÚµå
ºñ°í
262.5¹Ð¸®±×·¥
12 ¸Å
ÆÑ
8800543001302
8800543001357
14cm ¡¿ 10cm
262.5¹Ð¸®±×·¥
6 ¸Å
ÆÑ
8800543001302
8800543001340
14cm ¡¿ 10cm
262.5¹Ð¸®±×·¥
5 ¸Å
ÆÑ
8800543001302
8800543001333
14cm ¡¿ 10cm
262.5¹Ð¸®±×·¥
4 ¸Å
ÆÑ
8800543001302
8800543001326
14cm ¡¿ 10cm(ÀϹݾÈÀü»óºñÀǾàǰ)
262.5¹Ð¸®±×·¥
2 ¸Å
ÆÑ
8800543001302
8800543001319
14cm ¡¿ 10cm
ÁÖ¼ººÐÄÚµå
341700CPO
[µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
Çã°¡»çÇ× ¿ø¹®Á¶È¸
[Çã°¡»çÇ× ¿ø¹®Á¶È¸]
È¿´ÉÈ¿°ú
[ÀûÀÀÁõ º° °Ë»ö]
´ÙÀ½ Áõ»óÀÇ ÁøÅë¤ý¼Ò¿°(Ç׿°) : »ã, Ÿ¹Ú»ó, ±ÙÀ°Åë, °üÀýÅë, °ñÀýÅë, ¿ä(Ç㸮)Åë, ¾î±ú°á¸², ½Å°æÅë, ·ù¸¶Æ¼½ºÅëÁõ
¿ë¹ý¿ë·®
* Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
[󹿾à¾î]
1ÀÏ 1¢¦2ȸ ȯºÎ(Áúȯ ºÎÀ§)¿¡ ºÙÀδÙ.
±Ý±â
1) 30°³¿ù ÀÌÇÏÀÇ À¯¾Æ
2) ½ÀÁø, ¿Ì µî¿¡ ÀÇÇÑ ÇǺο°, »óóºÎÀ§
½ÅÁßÅõ¿©
1) Áö±Ý±îÁö ¾àÀ̳ª ÈÀåǰ µî¿¡ ÀÇÇÑ ¾Ë·¹¸£±â Áõ»ó(¿¹¸¦ µé¸é ¹ßÁø¤ý¹ßÀû(ÃæÇ÷µÇ¾î ºÓ¾îÁü), °¡·Á¿ò, ¿Ì µî¿¡ ÀÇÇÑ ÇǺο° µî)ÀÌ ³ªÅ¸³ ÀûÀÌ Àִ ȯÀÚ
2) º»ÀÎ ¶Ç´Â °¡Á·ÀÌ ¾Ë·¹¸£±â üÁúÀΠȯÀÚ
3) ½ÀÀ±(½À±â Âü)À̳ª ¹Ì¶õ(Áþ¹«¸§)ÀÌ ½ÉÇÑ È¯ÀÚ
4) ÀÇ»çÀÇ Ä¡·á¸¦ ¹Þ°í Àִ ȯÀÚ
5) ¼Ò¾Æ(°æ·ÃÀ» À¯¹ßÇÒ ¼ö ÀÖ´Ù)
6) ÀӺΠ¶Ç´Â ÀÓ½ÅÇϰí ÀÖÀ» °¡´É¼ºÀÌ ÀÖ´Â ¿©¼º
7) ¼öÀ¯ºÎ
ÀÌ»ó¹ÝÀÀ
ÀÌ ¾àÀÇ »ç¿ëÀ¸·Î ¹ßÁø¤ý¹ßÀû(ÃæÇ÷µÇ¾î ºÓ¾îÁü), °¡·Á¿ò µîÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â °æ¿ì¿¡´Â »ç¿ëÀ» ÁßÁöÇÏ°í ¾à»ç ¶Ç´Â ÀÇ»ç¿Í »óÀÇÇÑ´Ù.
Related FDA Approved Drug
±âÁØ ¼ººÐ:
METHYL SALICYLATE SALONPAS (MENTHOL; METHYL SALICYLATE)
±âÁØ ¼ººÐ:
MENTHOL ±âÁØ ¼ººÐ:
MENTHA OIL ±âÁØ ¼ººÐ:
CAMPHOR
Á¤º¸¿ä¾à
µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
ÄÚµå ¹× ºÐ·ùÁ¤º¸
Á¦Ç°Á¤º¸
º¹¾àÁ¤º¸
Ç׸ñ
³»¿ë
LACTmed ¹Ù·Î°¡±â
[¹Ù·Î°¡±â]
¾à¸®ÀÛ¿ë
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
Ãà¾àº¹¾àÁöµµ
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
º¹¾àÁöµµ
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
Pharmacokinetics
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸
[º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
º¸°ü»ó ÁÖÀÇ
Á¶Á¦½Ã ÁÖÀÇ
½É»çÁ¤º¸
ÇмúÁ¤º¸
Ç׸ñ
³»¿ë
DUR (ÀǾàǰ»ç¿ëÆò°¡)
º´¿ë±Ý±â :
°í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]
¿¬·É´ë±Ý±â :
°í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
µ¶¼ºÁ¤º¸
Camphor ¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â
Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do
Mechanism of Action
Menthol¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Menthol is classified as a calcium channel blocker. Calcium channel blockers are a class of drugs with effects on many excitable cells of the body, like the muscle of the heart, smooth muscles of the vessels or neuron cells. Calcium channel blockers work by blocking voltage-sensitive calcium channels in the heart and in the blood vessels. This prevents calcium levels from increasing as much in the cells when stimulated, leading to less contraction.
Pharmacology
Menthol¿¡ ´ëÇÑ Pharmacology Á¤º¸ Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. Menthol's ability to chemically trigger cold-sensitive receptors in the skin is responsible for the well known cooling sensation that it provokes when inhalated, eaten, or applied to the skin. It should be noted that menthol does not cause an actual drop in temperature.
Protein Binding
Menthol¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ Not Available
Half-life
Menthol¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ Not Available
Absorption
Menthol¿¡ ´ëÇÑ Absorption Á¤º¸ Not Available
Pharmacokinetics
Methyl SalicylateÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
Èí¼ö :
À§Àå°üÀ¸·ÎºÎÅÍ Àß Èí¼öµÈ´Ù.
¹þ°ÜÁø ÇǺθ¦ ÅëÇØ¼µµ Èí¼öµÉ ¼ö ÀÖ´Ù.
Mentha oilÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
¼Ò½Ç : Èí¼öµÈ ¾à¹°Àº glucuronide Æ÷ÇÕü·Î¼ ¼Òº¯ ¹× ´ãÁóÀ» ÅëÇØ ¹è¼³µÈ´Ù.
MentholÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
¼Ò½Ç : Èí¼öµÈ ¾à¹°Àº glucuronide Æ÷ÇÕü·Î¼ ¼Òº¯ ¹× ´ãÁóÀ» ÅëÇØ ¹è¼³µÈ´Ù.
Toxicity
Menthol¿¡ ´ëÇÑ Toxicity Á¤º¸ Menthol, DL: ORAL (LD50): Acute: 2900 mg/kg [Rat], 3100 mg/kg [Mouse]. DERMAL (LD50): Acute: 5001 mg/kg [Rabbit].
Drug Interactions
Menthol¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available
CYP450 Drug Interaction
[CYP450 TableÁ÷Á¢Á¶È¸]
Drug Target
[Drug Target]
Description
Camphor¿¡ ´ëÇÑ Description Á¤º¸ A bicyclic monoterpene ketone found widely in plants, especially cinnamomum camphora. It is used topically as a skin antipruritic and as an anti-infective agent. [PubChem]Menthol¿¡ ´ëÇÑ Description Á¤º¸ Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. It is a waxy, crystalline substance, clear or white in color, which is solid at room temperature and melts slightly above. The main form of menthol occurring in nature is (-)-menthol, which is assigned the (1R,2S,5R) configuration. Menthol has local anesthetic and counterirritant qualities, and it is widely used to relieve minor throat irritation.
Dosage Form
Menthol¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Cream TopicalGel TopicalLiquid NasalLiquid OralLiquid TopicalLozenge OralOintment TopicalPatch TopicalPowder TopicalSolution / drops OralSpray Topical
Drug Category
Camphor¿¡ ´ëÇÑ Drug_Category Á¤º¸ Anti-Infective Agents, LocalMenthol¿¡ ´ëÇÑ Drug_Category Á¤º¸ Antipruritics
Smiles String Canonical
Camphor¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC1(C)C2CCC1(C)C(=O)C2Menthol¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC(C)C1CCC(C)CC1O
Smiles String Isomeric
Camphor¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CC1(C)[C@H]2CC[C@]1(C)C(=O)C2Menthol¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
InChI Identifier
Camphor¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C10H16O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7H,4-6H2,1-3H3Menthol¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m1/s1
Chemical IUPAC Name
Camphor¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 1,7,7-trimethylbicyclo[2.2.1]heptan-2-oneMenthol¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ (1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol
»ç¿ëÀÚÄÁÅÙÃ÷
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2022-10-25
º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
¾Ë¸²
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.
°æ°í
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù.
Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â
Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡± ¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é
¿©±â ·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
[ÀǾàǰº´¿ë/¿¬·É´ë±Ý±â °í½Ã±Ù°Å·Î ¹Ù·Î°¡±â] Á¦¸ñ ¾øÀ½
2008³â 8¿ù 1ÀÏ ¾à°¡ÈÀÏ»ó 8¿ù´Þ ½Å±ÔµîÀç ¹× »èÁ¦µÇ´Â ǰ¸ñ Æ÷ÇÔÇÑ º´¿ë¿¬·É ±Ý±â ǰ¸ñ¸®½ºÆ® ±âÁØ
1. ÇöÀç °Ë»öÇÑ Á¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â Á¦Ç° Á¸Àç¿©ºÎ ¹× °Ë»ö
ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 Á¦Ç°³»¿ª °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
2. ¿¬·É´ë±Ý±â Á¸Àç¿©ºÎ
ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ ¿¬·É±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù